Enzymes Sustainable Alternatives with Remarkable Scope

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Come True Biomedical Inc

Come True Biomedical Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • February 2015
  • 56 pages

A textual analysis of the financial results for Come True Biomedical Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biopharmaceutical | Countries: China

Zhengyang Biomedical Technology Co Ltd

Zhengyang Biomedical Technology Co Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • February 2015
  • 56 pages

A textual analysis of the financial results for Zhengyang Biomedical Technology Co Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Biopharmaceutical

Alliqua Biomedical Inc

Alliqua Biomedical Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • February 2015
  • 56 pages

A textual analysis of the financial results for Alliqua Biomedical Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Biopharmaceutical

Schnell Biopharmaceuticals Incorporation

Schnell Biopharmaceuticals Incorporation

  • $ 55
  • Company report
  • by Wright Investors' Service
  • February 2015
  • 57 pages

A textual analysis of the financial results for Schnell Biopharmaceuticals Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Biopharmaceutical | Countries: South Korea

Shin Nippon Biomedical Laboratories Ltd

Shin Nippon Biomedical Laboratories Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • February 2015
  • 55 pages

A textual analysis of the financial results for Shin Nippon Biomedical Laboratories Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Biopharmaceutical

ABF Ingredients: Ingredients - Company Profile and SWOT Report

ABF Ingredients: Ingredients - Company Profile and SWOT Report

  • $ 125
  • Company report
  • by Canadean Ltd
  • February 2015
  • 15 pages

Product Synopsis Canadean's "ABF Ingredients: Ingredients - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, ...

Industries: Biopharmaceutical | Countries: United Kingdom, World

New Phase of Mab biosimilar knocks the door  Biosimilar Oppurtunities In Japan

New Phase of Mab biosimilar knocks the door Biosimilar Oppurtunities In Japan

  • $ 4 000
  • Industry report
  • by MP Advisors
  • February 2015
  • 65 pages

The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S. in adapting to biosimilar use. After nine years of continuous efforts by the JP government to promote increased use of generics (started in 2006 by launching ...

Industries: Biopharmaceutical | Countries: Japan

Omega Protein Corporation

Omega Protein Corporation

  • $ 55
  • Company report
  • by Wright Investors' Service
  • February 2015
  • 55 pages

A textual analysis of the financial results for Omega Protein Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biopharmaceutical

Competitor Analysis: Specific and Bispecific Her3 Antibodies

Competitor Analysis: Specific and Bispecific Her3 Antibodies

  • $ 275
  • Industry report
  • by La Merie Publishing
  • February 2015
  • 27 pages

Competitor Analysis: Specific and Bispecific Her3 Antibodies This Competitive Intelligence Report about Specific and Bispecific Her3 Antibodies provides a competitor evaluation in the field of recombinant specific antibodies targeting Her3 or bispecific antibodies targeting Her3 and Her2 or EGF-R o ...

Industries: Biopharmaceutical

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin

  • $ 412
  • Industry report
  • by La Merie Publishing
  • February 2015
  • 64 pages

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin provides a competitor evaluation in the field of recombinant antibodies targeting Her2 for treatment of ...

Industries: Biopharmaceutical

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.